Long-term effects of elevated gastrin levels on calcitonin secretion

Journal of Endocrinological Investigation

Volumn 29, Issue 9, 2006, Pages 771-775

  Erdogan, M F ^a   Gursoy, A ^a   Kulaksizoglu, M ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

C cell; Calcitonin; Gastrin; Pentagastrin

Indexed keywords

CALCITONIN; GASTRIN; HISTAMINE H2 RECEPTOR ANTAGONIST; LIOTHYRONINE; PENTAGASTRIN; PROTON PUMP INHIBITOR; THYROGLOBULIN; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; AGE; ARTICLE; BLOOD ANALYSIS; CELL HYPERPLASIA; CELL STIMULATION; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; HYPERGASTRINEMIA; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PERNICIOUS ANEMIA; PREVALENCE; SEX RATIO; SIDE EFFECT; THYROID PARAFOLLICULAR CELL; TREATMENT DURATION;

EID: 33845327155     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347369     Document Type: Article

References (14)

1. Kaserer K, Scheuba C, Neuhold N, et al. C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 1998, 22: 722-8.
2. Perry A, Molberg K, Albores-Saavedra J. Physiologic versus neoplastic C-cell hyperplasia of the thyroid. Cancer 1996, 77: 750-7.
3. Owyang C, Heath H 3rd, Sizemore GW, Go VL. Comparison of the effects of pentagastrin and meal-stimulated gastrin on plasma calcitonin in normal man. Am J Dig Dis 1978, 23: 1084-8.
4. Lamers CB, Hackeng WH, Thien T, van Tongeren JH. Serum concentrations of immunoreactive calcitonin in patients with hypergastrinemia. Digestion 1980, 20: 379-82.
5. Lazzaroni M, Sangaletti O, Bianchi Porro G. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients. Hepato-Gastroenterol 1992, 39: 366-70.
6. Lind T, Cederberg C, Forssell H, Olausson M, Olbe L. Relationship between reduction of gastric acid secretion and plasma gastrin concentration during omeprazole treatment. Scand J Gastroenterol 1988, 23: 1259-66.
7. Fahrenkrug J, Schaffalitzky de Muckadell OB, Rehfeld JF. Serum calcitonin in hypergastrinemia due to achlorhydria. Acta Endocrinol (Copenh) 1977, 86: 140-5.
8. Becker KL, Silva OL, Cyrus J, Snider RH Jr, Moore CF. Hypercalcitonemia in pernicious anemia. Experientia 1980, 36: 1330-1.
9. Brandsborg M, Nielsen HE, Brandsborg O, Olsen KJ, Lovgreen NA. The role of serum gastrin in the secretion of calcitonin: studies in patients with pernicious anemia and in healthy subjects. Scand J Gastroenterol 1980, 15: 23-8.
10. Rumenapf G, Schwille PO, Wagner W, Tiecks FP, Fries W, Galewski D. Highly selective vagotomy in the rat: effects on bone and mineral metabolism. Scand J Gastroenterol 1994, 29: 232-7.
11. Persson P, Grunditz T, Axelson J, Sundler F, Hakanson R. Cholecystokinins but not gastrin-17 release calcitonin from thyroid C-cells in the rat. Regul Pept 1998, 21: 45-56.
12. Heynen G, Brassine A, Daubresse JC, et al. Lack of clinical and physiological relationship between gastrin and calcitonin in man. Eur J Clin Invest 1981, 11: 331-5.
13. Erdogan MF, Gullu S, Baskal N, Uysal AR, Kamel N, Erdogan G. Omeprazole: calcitonin stimulation test for the diagnosis follow-up and family screening in medullary thyroid carcinoma. J Clin Endocrinol Metab 1997, 82: 897-9.
14. Babior BM, Bunn HF. Megaloblastic anemias. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds. Harrison's Principles of Internal Medicine. 15th ed. New York: McGraw-Hill. 2001, 674-80